BP
CVS icon

Ballentine Partners’s CVS Health CVS Stock Holding History

Ballentine Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-27,500
Closed -$2.85M – 238
2016
Q1 		$2.85M Hold
27,500
– – 0.25% 35
2015
Q4 		$2.69M Hold
27,500
– – 0.26% 33
2015
Q3 		$26.5M Hold
27,500
– – 2.79% 13
2015
Q2 		$2.88M Buy
+27,500
New +$2.81M 0.28% 29

Other funds holding CVS

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
CAM
Cacti Asset Management Atlanta, Georgia $1.99B AUM 86.33% 1-Year Est. Return

Ballentine Partners's CVS Position: Q2 2026 in Review

Ballentine Partners increased its CVS Health (CVS) stake by 8.7% in Q2 2026, buying an estimated $55.3K and bringing the position to 7,740 shares worth $801K. The position accounts for 0.01% of the portfolio, ranked #422.

Ballentine Partners first reported a position in CVS in Q3 2013 and has held it in 52 quarters since. The position peaked at $1.22M in Q4 2022. 351 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Ballentine Partners held 7,740 shares of CVS Health worth $801K as of Q2 2026.
  • Ballentine Partners bought 619 CVS Health shares in Q2 2026, an estimated $55.3K.
  • CVS Health made up 0.01% of Ballentine Partners's portfolio in Q2 2026, its #422 holding.
  • Ballentine Partners first reported a position in CVS Health in Q3 2013 and has held it in 52 quarters since.
  • Ballentine Partners's CVS Health position peaked at $1.22M in Q4 2022.
  • 351 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.